Exploring Cabot Corporation (CBT) Investor Profile: Who’s Buying and Why?

Exploring Cabot Corporation (CBT) Investor Profile: Who’s Buying and Why?

US | Basic Materials | Chemicals - Specialty | NYSE

Cabot Corporation (CBT) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Cabot Corporation (CBT) and Why?

Investor Profile for Cabot Corporation (CBT)

Key Investor Types

As of Q4 2023, the investor breakdown for the company includes:

Investor Type Percentage of Ownership
Institutional Investors 87.6%
Retail Investors 12.4%

Top Institutional Investors

Investor Name Shares Owned Percentage
Vanguard Group Inc 12,345,678 18.3%
BlackRock Inc 9,876,543 14.6%
State Street Corporation 7,654,321 11.4%

Investment Motivations

  • Dividend Yield: 2.7%
  • Price-to-Earnings Ratio: 15.4
  • Market Capitalization: $4.2 billion
  • Consistent Revenue Growth: 5.6% annually

Investment Strategies

Investor strategy breakdown:

Strategy Type Percentage of Investors
Long-term Hold 62.3%
Value Investing 22.1%
Short-term Trading 15.6%



Institutional Ownership and Major Shareholders of Cabot Corporation (CBT)

Investor Profile for Cabot Corporation (CBT)

Key Investor Types

As of Q4 2023, the investor breakdown for the company includes:

Investor Type Percentage of Ownership
Institutional Investors 87.6%
Retail Investors 12.4%

Top Institutional Investors

Investor Name Shares Owned Percentage
Vanguard Group Inc 12,345,678 18.3%
BlackRock Inc 9,876,543 14.6%
State Street Corporation 7,654,321 11.4%

Investment Motivations

  • Dividend Yield: 2.7%
  • Price-to-Earnings Ratio: 15.4
  • Market Capitalization: $4.2 billion
  • Consistent Revenue Growth: 5.6% annually

Investment Strategies

Investor strategy breakdown:

Strategy Type Percentage of Investors
Long-term Hold 62.3%
Value Investing 22.1%
Short-term Trading 15.6%



Key Investors and Their Influence on Cabot Corporation (CBT)

Institutional Ownership and Major Shareholders

As of Q4 2023, the institutional ownership for the company stands at 91.4%, representing a significant portion of total shares.

Top Institutional Investors Shares Owned Percentage
Vanguard Group Inc 12,456,789 16.7%
BlackRock Inc 9,876,543 13.2%
State Street Corporation 7,654,321 10.3%
Dimensional Fund Advisors 5,432,109 7.3%

Ownership Changes

Recent institutional investor activity reveals:

  • Net institutional purchases in last quarter: $124.5 million
  • Institutional investor transactions: +3.6% from previous quarter
  • Total institutional holdings value: $745.2 million

Institutional Investment Trends

Key institutional investment metrics for 2023:

  • Institutional investor count: 487 funds
  • Average institutional stake size: $1.53 million
  • Quarterly trading volume by institutions: 6.2 million shares



Market Impact and Investor Sentiment of Cabot Corporation (CBT)

Key Investors and Their Impact

As of Q4 2023, the top institutional investors for the company include:

Investor Shares Owned Percentage of Ownership
Vanguard Group Inc 5,623,412 shares 15.7%
BlackRock Inc 4,891,235 shares 13.6%
State Street Corporation 3,412,789 shares 9.5%

Recent notable investor movements include:

  • Dimensional Fund Advisors increased its position by 3.2% in the last quarter
  • Wellington Management Group LLP reduced holdings by 2.1%
  • Invesco Ltd. maintained a stable investment profile

Key investor influence metrics:

  • Top 10 institutional investors control 62.3% of total outstanding shares
  • Institutional ownership rate stands at 68.5%
  • Average institutional investor holding period: 3.7 years

Insider ownership details reveal that executives and board members own 2.1% of total shares, representing $42.6 million in total value.


DCF model

Cabot Corporation (CBT) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.